Stephan B, Rustenbach S, Ben-Anaya N, Augustin M, Boehncke W, Hertl M
J Clin Med. 2024; 13(13).
PMID: 38999279
PMC: 11242749.
DOI: 10.3390/jcm13133713.
Edwards S, Karner C, Jhita T, Barton S, Marceniuk G, Yiu Z
Health Technol Assess. 2024; 28(4):1-113.
PMID: 38343072
PMC: 11017148.
DOI: 10.3310/LEXB9006.
Song Y, Yao L, Li S, Zhou J
Front Microbiol. 2023; 14:1294056.
PMID: 38029150
PMC: 10667470.
DOI: 10.3389/fmicb.2023.1294056.
Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S
Am J Clin Dermatol. 2023; 24(5):837-847.
PMID: 37233897
PMC: 10213585.
DOI: 10.1007/s40257-023-00788-2.
Rajagopalan M, Saraswat A, Chandrashekar B, Dhar S, Dogra S, Tahiliani S
Indian Dermatol Online J. 2022; 13(5):585-599.
PMID: 36304637
PMC: 9595170.
DOI: 10.4103/idoj.idoj_189_22.
Breastfeeding by a mother taking cyclosporine for nephrotic syndrome.
Li R, Zhang C, Wang H, An Y
Int Breastfeed J. 2022; 17(1):72.
PMID: 36253832
PMC: 9578242.
DOI: 10.1186/s13006-022-00514-4.
Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?.
Arents B, van Zuuren E, Vermeulen S, Schoones J, Fedorowicz Z
Br J Dermatol. 2022; 186(5):792-802.
PMID: 34984668
PMC: 9325494.
DOI: 10.1111/bjd.20972.
Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis.
Sun H, Keller E, Suresh H, Sebaratnam D
JAAD Int. 2021; 5:1-8.
PMID: 34816130
PMC: 8593743.
DOI: 10.1016/j.jdin.2021.06.004.
A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine.
Pandey S, Tripathi P, Gupta A, Yadav J
Drug Deliv Transl Res. 2021; 12(7):1541-1555.
PMID: 34550552
DOI: 10.1007/s13346-021-01059-5.
COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology.
Degirmenci M, Yalcindag F, Tugal-Tutkun I
Turk J Ophthalmol. 2021; 51(4):231-242.
PMID: 34461710
PMC: 8411289.
DOI: 10.4274/tjo.galenos.2021.68252.
COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management.
Hossain M, Hasana S, Al Mamun A, Uddin M, Wahed M, Sarker S
Front Pharmacol. 2020; 11:563478.
PMID: 33178016
PMC: 7596415.
DOI: 10.3389/fphar.2020.563478.
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic.
Cardinale F, Ciprandi G, Barberi S, Bernardini R, Caffarelli C, Calvani M
Ital J Pediatr. 2020; 46(1):84.
PMID: 32546234
PMC: 7296524.
DOI: 10.1186/s13052-020-00843-2.
Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review.
Nowaczyk J, Makowska K, Rakowska A, Sikora M, Rudnicka L
Dermatol Ther (Heidelb). 2020; 10(3):387-399.
PMID: 32270396
PMC: 7211785.
DOI: 10.1007/s13555-020-00370-2.
COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.
Wang C, Rademaker M, Baker C, Foley P
Australas J Dermatol. 2020; 61(3):210-216.
PMID: 32255510
PMC: 7262046.
DOI: 10.1111/ajd.13313.
Psoriasis and Treatment: Past, Present and Future Aspects.
Reid C, Griffiths C
Acta Derm Venereol. 2020; 100(3):adv00032.
PMID: 31971601
PMC: 9128930.
DOI: 10.2340/00015555-3386.
Double trouble: ciclosporin-simvastatin coinduced rhabdomyolysis.
Hafouda Y, Sharma A, Li V, Yesudian P
BMJ Case Rep. 2019; 12(11).
PMID: 31772127
PMC: 6887404.
DOI: 10.1136/bcr-2018-225971.
